Inspira Pharmaceuticals (IP) is forming a possible new therapy for COVID-19. IP asserts that its in-lab plant-based molecular formulation has killed over 95% of the SARS-CoV-2 virus. The company aims to understand whether a COVID-19 patient can safely inhale the formulation directly into their lungs as an effective treatment. IP has secured cornerstone investment from biotech angel investors and a Singaporean Venture Capitalist (VC) for its formula. IP argues that its technology has the potential for addressing other respiratory infections such as cystic fibrosis, influenza and the common cold in the coming months. The company will use the investment to develop an effective new drug, which will include further laboratory analysis, safety testing, and preparation for human trials.
days to go:
Expired
investment:
£357,179
Virtual Reality Universe provides location based virtual and augmented reality experiences. Expensive systems and hardware requirements put such experiences out of reach for most consumers. Virtual Reality Universe aims are to change that by placing units in busy shopping areas and sports arenas.
(SEIS Partial)
days to go:
Expired
investment:
£57,900
An innovation event that displays the greatest in medical healthcare technologies within exhibitions, conferences and workshops. GIANT Health has over 2000 delegates registered, with 235 speakers and 33 exhibitors whilst being sponsored by 8 global companies. Current revenue streams consist of event ticket sales, partnership packages, stage demos, etc. Events are held across Europe, with international expansion in the next phase.
days to go:
Expired
investment:
£62,770
Apps4Arts turns the once paper driven medium of festival programming into an elegently designed app. Organisers can now publish interactive guides from their desktops. No coding or design experienced is required.
days to go:
Expired
investment:
£27,980
Empowering landlords with the tools they need to efficiently manage the letting process of their properties. Honest Homes aims to cut out intermediaries and instead offers transparent systematic guides via their online platform to save UK landlords and tenants time and money. Their service provides users with abilities to create contracts, ensure compliance and perform monetary transactions for the collection and payment of deposits and rent.
Honest Homes' all-in-one solution aims to reduce average landlord admin costs from 12%, to 3%. Their service is designed to be fully automated and includes features such as reviews and ratings for both landlords and tenants. The company is aiming to host 1.8% of UK addresses by their fifth year, which represents around 60k listings and they are also planning to expand their services into Europe.
days to go:
Expired
investment:
£166,670
Ofixu is an online platform that aim to help you with your office requirements. If you have underutilised space then Ofixu will help you earn extra cash by listing it at no extra cost. On the other hand, if you're an entrepreneur looking to rent an office, you can find one local to you by using Ofixu's worldwide search function.
days to go:
Expired
investment:
£151,762
Big Couch is the 'crewfunding' platform that empowers filmmakers to connect with crews that invest in projects they believe in. Crews accept lower upfront fees in return for profit shares and deferred payment. Film producers optimise their budgets up to 20%.
days to go:
Expired
investment:
£403
Propnology is a crowdfunding platform specifically designed for property. Founded in 2014, their aim is to encourage a more diverse group of individuals to invest. Propnology allows users to invest in property from as little as £500.
days to go:
Expired
investment:
£57,209
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.
days to go:
Expired
investment:
£270,543
Like a lot of young independent British film companies, 721 Productions had only a modest budget with which to enter the $36 billion global film industry in 2014 (an industry that seems recession proof given that global box office revenues have seen a 22% increase since 2009).
Despite the low budget, director Paul Emmanuel still produced a piece of brilliance with ‘The Maid’ - a romantic drama that hit the silver screen in early 2014 and subsequently went on to pick up various film accolades, including multiple awards, a nomination for Best UK Feature Film and screenings at the prestigious London and New York film festivals.
Since the overwhelming response to what was 721 Productions' very first film, the team has been hard at work on its latest film ‘Secrets of the Lost Souls’.
Paul Emmanuel is once again steering the ship second time around – albeit with a greater depth of industry connections and knowhow compared to the first. He is working alongside other talented and versatile filmmakers David C. G. Hare – who himself has built an impressive career over the past 15 years – and the award-winning cinematographer Steven Marshall who has over 9 years experience in his field and has worked on movies screened at film festivals in Cannes, Venice and Berlin.
The latest film production will cost £80,000 – you'd be forgiven for thinking that that's a small amount for the production of a movie. But with advanced digital cinema technology available to modern-day filmmakers at reasonable prices, costs can be contained. The film ‘Paranormal Activity’ for example, cost $15,000 to make and grossed over $107,000,000 at the box office – testament not only to the relatively small investment these types of productions need, but also to why Horror/Action genres are widely recognised as offering the highest rates of return on investment in the movie industry.
Like Paranormal Activity ‘Secrets of the Lost Souls’ is a supernatural horror thriller aimed at the more lucrative US market.
Production is scheduled to begin early next year and 721 Productions wants to make investors become part of the journey – one featuring ongoing film updates, special mentions, exclusive screenings, site visits, film previews and a wrap party. How far you travel on that journey with the production team depends on how much you invest.
Investors pledging money to this pitch will receive exciting investor rewards and shares in a movie from what is an emerging British film production company. Check out the 'rewards' section for more details.
days to go:
Expired
investment:
£24,700
